Abstract:Introduction Diabetes leads to endothelial dysfunction, a main determinant of several cardiovascular diseases. The molecular mechanisms underlying the effects of hyperglycemia in endothelial cells are not fully characterized. Autophagy, the intracellular process by which the cell digests and recycles senescent or damaged cytoplasmic elements, exerts cardiovascular protective effects, limiting cardiac and vascular injury in the presence of stress. However, it is unclear how hyperglycemia modulates autophagy in endothelial cells. Purpose In this study, we elucidated the role of autophagy in vascular damage induced by diabetes. We also tested whether the restoration autophagy attenuates diabetes-induced endothelial damage. Methods We evaluated the effects of high-glucose (HG, 30 mM for 6 and 24 hours) on markers of endothelial function, autophagy, autophagic flux, and mitophagy in human umbilical endothelial cells (HUVEC) in vitro and in mesenteric arteries from wild-type mice (WT) ex vivo. We tested the effects of autophagy reactivation using the natural polyamine spermidine or ATG7 overexpression (ATG7ov) on apoptosis and angiogenesis in HUVEC treated with HG. Vascular reactivity experiments in the presence of autophagy activation were performed in HG-treated mouse mesenteric arteries and human saphenous veins from patients with peripheral artery disease. Finally, we evaluated the level of autophagy in the mammary arteries of newly discovered diabetic patients undergoing coronary artery bypass graft surgery. Results We found that HG reduces autophagy (0.6 fold p<0.05) and mitophagy (1.5 fold p<0.001) in HUVECs. We also demonstrated that endothelial cells undergoing hyperglycemia fail to activate autophagy under hypoxic conditions (0.6 fold p<0.05). Reactivation of autophagy by ATG7ov rescues apoptosis (0.52 fold p<0.05) and angiogenesis (2.3 fold p<0.05) in HUVEC treated with HG. We further observed that HG exacerbates endothelial dysfunction in a mouse model of genetic inhibition (Beclin 1 +/- mice), compared to WT mice (-19.16 % +-4.97 SEM vs -48.39 % +-2.18 SEM p<0.001). Mechanistically, HG increases cellular acetylation status (0.7 fold p<0.05) and activates p300 (1 fold p<0.05), an autophagy inhibitor. ATG7ov or spermidine, a p300 inhibitor, rescue endothelial-dependent relaxation in mesenteric arteries of WT mice treated with HG (ATG7ov -62.48 % +-5.16 SEM; SP -63.01 +-3.22 SEM; HG -40.67 % +-3.82 p<0.001). Finally, we observed reduced levels of autophagy in mammary arteries from diabetic patients and demonstrated that SP improves vascular function in human saphenous veins (-37.6 % +-12.76 SEM vs -12.52 % +-5.6 SEM p<0.001). Conclusion Our results suggest that the impairment of autophagy is a strong contributor of diabetes induced-endothelial dysfunction. Targeting autophagy may represent a valid therapeutic strategy to counteract the cardiovascular consequences of metabolic stress.

The Role of Autophagy of Endothelial Cells in Diabetic Vascular Diseases

Autophagy plays a protective role in advanced glycation end product-induced apoptosis of vascular endothelial cells

Autophagy protects against senescence and apoptosis via the RAS-mitochondria in high-glucose-induced endothelial cells.

Physiological and pathological characteristics of vascular endothelial injury in diabetes and the regulatory mechanism of autophagy

Redefining the Role of Autophagy in Diabetic Vascular Diseases

Autophagy Protects Human Brain Microvascular Endothelial Cells Against Methylglyoxal-Induced Injuries, Reproducible in A Cerebral Ischemic Model in Diabetic Rats

Protective or Harmful: The Dual Roles of Autophagy in Diabetic Retinopathy

The role of glucagon-like peptide-1/GLP-1R and autophagy in diabetic cardiovascular disease

Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential

The role of autophagy in the treatment of type II diabetes and its complications: a review

Autophagy behavior in Endothelial Cell Dysfunction

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

Restoration of autophagy reduces diabetes-induced endothelial dysfunction

Traditional Chinese Medicine and Its Active Substances Reduce Vascular Injury in Diabetes Via Regulating Autophagic Activity

Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications

Targeting autophagy with natural products as a potential therapeutic approach for diabetic microangiopathy

[Research progress of traditional Chinese medicine in regulating autophagy for intervening in diabetic cardiomyopathy]

Autophagy in diabetes: β-cell dysfunction, insulin resistance, and complications

Role of β‐cell autophagy in β‐cell physiology and the development of diabetes

The role of autophagy in cardiovascular disease: Cross-interference of signaling pathways and underlying therapeutic targets

Endogenous Protective Factors and Potential Therapeutic Agents for Diabetes-Associated Atherosclerosis